Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP

BACKGROUND/AIMS: This study was to evaluate the clinical significance of infusion-related reaction (IRR) of rituximab in diffuse large B-cell lymphoma (DLBCL) patients who received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) as a first-line chemotherapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyoung Min, Keam, Bhumsuk, Ha, Hyerim, Kim, Miso, Jung, Jae-Woo, Song, Woo-Jung, Kim, Tae Min, Jeon, Yoon Kyung, Kang, Hye-Ryun, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610184/
https://www.ncbi.nlm.nih.gov/pubmed/29151283
http://dx.doi.org/10.3904/kjim.2017.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610184/
https://www.ncbi.nlm.nih.gov/pubmed/29151283
http://dx.doi.org/10.3904/kjim.2017.036

Ejemplares similares